LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately ...
Scientists have long studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order ...
A Johns Hopkins study finds teens with cannabis use disorder face higher risks of schizophrenia, depression, and anxiety than ...
How does dopamine control both movement and learning? New research reveals that acetylcholine acts as a "switch" for dopamine ...
LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately 460 patients Primary endpoint to evaluate change in PANSS total score at week ...
2d
New Biomarker Discovered For Cognitive Symptoms Of Schizophrenia, Could Serve As Drug Target: Study
A study has found a new biomarker of schizophrenia, which could also serve as a drug target for treating cognitive symptoms ...
Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to ...
A psychiatric nurse practitioner on the Hi-Line is using transcranial magnetic stimulation to help patients overcome ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results